Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNexus Gene Lab (BGLC) Exchange Rate Effect (2020 - 2025)

BioNexus Gene Lab's Exchange Rate Effect history spans 6 years, with the latest figure at $28535.0 for Q3 2025.

  • For Q3 2025, Exchange Rate Effect fell 94.95% year-over-year to $28535.0; the TTM value through Sep 2025 reached -$122796.0, down 124.71%, while the annual FY2024 figure was $40339.0, 115.53% up from the prior year.
  • Exchange Rate Effect for Q3 2025 was $28535.0 at BioNexus Gene Lab, down from $215220.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $565319.0 in Q3 2024 and bottomed at -$409601.0 in Q4 2024.
  • The 5-year median for Exchange Rate Effect is -$33517.0 (2021), against an average of -$9343.2.
  • The largest annual shift saw Exchange Rate Effect soared 966.13% in 2022 before it crashed 971.53% in 2024.
  • A 5-year view of Exchange Rate Effect shows it stood at $21764.0 in 2021, then skyrocketed by 966.13% to $232032.0 in 2022, then crashed by 79.75% to $46998.0 in 2023, then plummeted by 971.53% to -$409601.0 in 2024, then surged by 106.97% to $28535.0 in 2025.
  • Per Business Quant, the three most recent readings for BGLC's Exchange Rate Effect are $28535.0 (Q3 2025), $215220.0 (Q2 2025), and $43050.0 (Q1 2025).